TRANSGENIC ANIMALS AND RECOMBINANT HOST CELLS COMPRISING SPECIFIC GENE VARIANTS AND METHODS OF CREATING SAME

METHOD FOR PROMOTING SEXUAL MATURATION OF FISH

METHOD OF GENETIC MANIPULATION OF NEURAL CELLS IN GYRENCEPHALIC FETAL BRAIN AND USES THEREOF

TRANSGENIC ANIMAL HAVING MODIFIED MYOSTATIN GENE

VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME

METHODS OF TREATMENT WITH AMINOLEVULINIC ACID SYNTHASE 2 (ALAS2) MODULATORS

CONTROLLED GENE EXPRESSION METHODS AND MEANS

Method for Constructing Murine Model with Mutations in Csf1r Gene and Application thereof

LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES

GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)

Opsins as Chemosensory Receptors and Related Methods

DOWN-REGULATION OF ENDOGENOUS GENES

A GENETICALLY MODIFIED IMMUNODEFICIENT MOUSE EXPRESSING HUMAN OR HUMANIZED APP AND MUTATED HUMAN PSEN1

GENERATION OF SURROGATE SIRES AND DAMS BY ABLATION OF ENDOGENOUS GERMLINE

JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR

ANIMAL MODEL, METHODS FOR MAKING AND USING THEREOF, AND COMPOSITION FOR TREATING ATAXIA

ENGINEERED CATFISH AND USES THEREOF

NON-HUMAN ANIMALS HAVING A LIMITED LAMBDA LIGHT CHAIN REPERTOIRE EXPRESSED FROM THE KAPPA LOCUS AND USES THEREOF

SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF

ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN SELECTED NEURONAL CELL POPULATIONS

MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION

COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION

GENETIC MODIFICATION OF PIGS FOR XENOTRANSPLANTATION

Genetically modified rat models for severe combined immunodeficiency (SCID)

Human Genomic Construct Reporter Cells and Mouse Models to Screen Therapeutics against Microglia-expressed Disease Associated Genes

Self-Limiting Noctuids

NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX

Synthesis of Non-Native Proteins in Bombyx Mori by Modifying Sericin Expression

Genetically modified rat models for severe combined immunodeficiency (SCID)

Non-human animals models of retinoschisis

Non-human animals having a humanized signal-regulatory protein gene

MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI

Transgenic mouse model of Neurofibromatosis type 1

loss of function rodent model

COMPOSITIONS AND METHODS FOR DETERMINING GENETIC POLYMORPHISMS IN THE TMEM216 GENE

FISH AND METHOD FOR PRODUCING FISH

HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION

Non-human animals having a humanized signal-regulatory protein gene

Mouse with cholinergic neuron-specific inactivated ANO1 gene

Transgenic mice with inducible neuron-specific inactivation of HuR gene and method of screening

Repressors of viral infection

Engineering of Humanized Kidney by Genetic Complementation

Animal model of Angelman Syndrome

Long germline DH genes and long HCDR3 antibodies

Non-human animals having a humanized signal-regulatory protein gene

ANIMAL MODEL FOR STUDYING ZCCHC6 IN BONE DISEASE AND DEVELOPMENT

Non-human animals expressing humanized C1Q complex

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

High-throughput mouse model for optimizing antibody affinities

Genetically modified rat models for severe combined immunodeficiency (SCID)

Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44

Non-human animal models of retinoschisis

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

Non-human animals having a humanized signal-regulatory protein gene

TRANSGENIC ANIMAL MODELS FOR CYSTIC FIBROSIS

Genetic modification of pigs for xenotransplantation

Non-human animals having a humanized signal-regulatory protein gene

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

Method for treating arthritis using IK factor or nucleic acid encoding IK factor

Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications

Non-human animals having a humanized signal-regulatory protein gene

High-throughput mouse model for optimizing antibody affinities

TRANSGENIC MOUSE MODELS FOR MC4R

Production of fertile XY female animals from XY ES cells

Genetically modified cells, tissues, and organs for treating disease

HUMANIZED MOUSE MODEL FOR STUDY OF BONA FIDE HEPATITIS VIRUS INFECTION AND USE THEREOF

Non-human animals having a humanized signal-regulatory protein gene

Treatment of muscular dystrophy

Animal models of neurological disorders

Normalization of the enterohepatic circulation in animals with a chimeric humanized liver

Non-human animals having a humanized signal-regulatory protein gene

Non-human animals having a humanized signal-regulatory protein gene

Production of fertile XY female animals from XY ES cells

Soluble protein CD5 or CD6 for the treatment of cancer or tumor or for use as an adjuvant

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

Genetically engineered mouse model for autism spectrum disorder having deletion of gene and use thereof

Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

Animal models of neurological disorders

Genetically modified rat models for severe combined immunodeficiency (SCID)

GENOME EDITING OF GENES INVOLVED IN ADME AND TOXICOLOGY IN ANIMALS

GENOMIC EDITING OF GENES INVOLVED IN MACULAR DEGENERATION

INCREASING LIFESPAN BY MODULATION OF WWP-1 AND UBC-18

Production of fertile XY animals from XY ES cells

ASSAY FOR SCREENING ANTIDEPRESSANTS

TRANSGENIC MICE HAVING A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PHENOTYPE, EXPERIMENTAL USES AND APPLICATIONS

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions

Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A

Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications

TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL

GENOME EDITING OF GENES ASSOCIATED WITH TRINUCLEOTIDE REPEAT EXPANSION DISORDERS IN ANIMALS

Method of deleting an IgM gene in an isolated rat cell

Methods of increasing muscle mass using follistatin-like related gene (FLRG)

ANIMAL MODEL FOR THE SELECTION AND VALIDATION OF AGENTS ACTIVE AGAINST PULMONARY EMPHYSEMA AND COLORECTAL CANCER

Models of thrombotic thrombocytopenic purpura and methods of use thereof

Novel gene disruptions, compositions and methods relating thereto

Increasing lifespan by modulation of WWP-1 and UBC-18

Model of Alzheimer's Disease

Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

Use of AIM3 acting as a tumor suppressor

Artificial human chromosome containing human antibody a light chain gene

Novel use of aim 3 acting as a tumor suppressor

Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications

A4B2 nicotinic acetylcholine receptors with reduced or increased nicotine sensitivity and transgenic mouse model for the same